{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T18:16:01Z","timestamp":1758478561612},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:00:00Z","timestamp":1456876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Reduction of myelin in peripheral nerve causes critical demyelinating diseases such as chronic inflammatory demyelinating polyneuropathy, Guillain-Barre syndrome, etc. Clinical monitoring of these diseases requires rapid and non-invasive quantification of demyelination. Here we have developed formulation of nerve conduction velocity (NCV) in terms of demyelination considering electric circuit model of a nerve having bundle of axons for its quantification from NCV measurements. This approach has been validated and demonstrated with toad nerve model treated with crude <jats:italic>Naja kaouthia<\/jats:italic> (NK) venom and also shows the effect of Phospholipase A<jats:sub>2<\/jats:sub> and three finger neurotoxin from NK-venom on peripheral nerve. This opens future scope for non-invasive clinical measurement of demyelination.<\/jats:p>","DOI":"10.1038\/srep22385","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T11:12:04Z","timestamp":1456917124000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Quantifying Demyelination in NK venom treated nerve using its electric circuit model"],"prefix":"10.1038","volume":"6","author":[{"given":"H. K.","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Doley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. P.","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,2]]},"reference":[{"key":"BFsrep22385_CR1","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nrn1746","volume":"6","author":"KR Jessen","year":"2005","unstructured":"Jessen, K. R. & Mirsky, R. The origin and development of axon ensheathment and myelin growth. Nat. Rev. Neurosci. 6, 671\u2013690 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFsrep22385_CR2","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.semcdb.2010.09.010","volume":"22","author":"MN Rasband","year":"2011","unstructured":"Rasband, M. N. Composition, assembly and maintenance of excitable membrane domains in myelinated axons. Semin. Cell Dev. Biol. 22, 178\u2013184 (2011).","journal-title":"Semin. Cell Dev. Biol."},{"key":"BFsrep22385_CR3","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10867-006-9008-x","volume":"32","author":"DL Stephanova","year":"2006","unstructured":"Stephanova, D. L., Daskalova, M. S. & Alexandrov, A. S. Differences in membrane properties in simulated case of demyelinating neuropathies, intermodal focal demyelination with conduction block. J. Biol. Phys. 32, 129\u2013144 (2006).","journal-title":"J. Biol. Phys."},{"key":"BFsrep22385_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s11910-007-0023-5","volume":"7","author":"TB Toothaker","year":"2007","unstructured":"Toothaker, T. B. & Brannagan, T. H. Chronic inflammatory demyelinating polyneuropathies: current treatment strategies. Curr. Neurol. Neurosci. Rep. 7(1), 63\u201370 (2007).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFsrep22385_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"BVD Berg","year":"2014","unstructured":"Berg, B. V. D. et al. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat. Rev. Neurol. 10, 469\u2013482 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"BFsrep22385_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11910-007-0022-6","volume":"7","author":"S Kuwabara","year":"2007","unstructured":"Kuwabara, S. Guillain-Barre Syndrome. Curr. Neurol. Neurosci. Rep. 7(1), 57\u201362 (2007).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"BFsrep22385_CR7","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/nbt.1764","volume":"29","author":"MA Whitney","year":"2011","unstructured":"Whitney, M. A. et al. Fluorescent peptides highlight peripheral nerves during surgery in mice. Nat. Biotechnol. 29(4), 352\u2013356 (2011).","journal-title":"Nat. Biotechnol."},{"key":"BFsrep22385_CR8","unstructured":"Goldman, L. & Ausiello, D. Shy ME. Peripheral neuropathies. Cecil Medicine, 23rd edn. (eds. Goldman, L. ) Ch. 446 (Elsevier, Philadelphia, 2007)."},{"key":"BFsrep22385_CR9","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1113\/jphysiol.1952.sp004764","volume":"117","author":"AL Hodgkin","year":"1952","unstructured":"Hodgkin, A. L. & Huxley, A. F. A quantitative description of membrane and its application to conduction and excitation in nerve. J. Physiol. 117, 500\u2013544 (1952).","journal-title":"J. Physiol."},{"key":"BFsrep22385_CR10","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1042\/bj1590273","volume":"159","author":"NL Banik","year":"1976","unstructured":"Banik, N. L., Gohil, K. & Davison, A. N. The action of Snake Venom, Phospholipase A and Trypsin on Purified Myelin in vitro. Biochem. J. 159, 273\u2013277 (1976).","journal-title":"Biochem. J."},{"key":"BFsrep22385_CR11","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.toxicon.2008.03.014","volume":"51","author":"AK Mukherjee","year":"2008","unstructured":"Mukherjee, A. K. Phospholipase A2-interacting weak neurotoxins from venom of monocled cobra Naja kaouthia display cell-specific cytotoxicity. Toxicon 51, 1538\u20131543 (2008).","journal-title":"Toxicon"},{"key":"BFsrep22385_CR12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.toxicon.2004.09.014","volume":"45","author":"AY Ogay","year":"2005","unstructured":"Ogay, A. Y., Rzhevsky, D. I., Murashev, A. N., Tsetlin, V. I. & Utkin, Y., N. Weak neurotoxin from Naja kaouthia cobra venom affects haemodynamic regulation by acting on acetylcholine receptors. Toxicon 45, 93\u201399 (2005).","journal-title":"Toxicon"},{"key":"BFsrep22385_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.bbagen.2006.09.021","volume":"1770","author":"AK Mukherjee","year":"2007","unstructured":"Mukherjee, A. K. Correlation between the phospholipids domains of the target cell membrane and the extent of Naja Kaouthia PLA2-induced membrane damage: Evidence of distinct catalytic and cytotoxic sites in PLA2 molecules. Biochim. Biophys. Acta 1770(2), 187\u2013195 (2007).","journal-title":"Biochim. Biophys. Acta"},{"key":"BFsrep22385_CR14","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.toxicon.2003.11.002","volume":"42","author":"RM Kini","year":"2003","unstructured":"Kini, R. M. Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzyme. Toxicon 42, 827\u2013840 (2003).","journal-title":"Toxicon"},{"key":"BFsrep22385_CR15","first-page":"693","volume":"58","author":"RM Kini","year":"2011","unstructured":"Kini, R. M. Evolution of three-finger toxins - A versatile mini protein scaffold. Acta Chim. Slov. 58, 693\u2013701 (2011).","journal-title":"Acta Chim. Slov."},{"key":"BFsrep22385_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.toxicon.2010.07.010","volume":"56","author":"RM Kini","year":"2010","unstructured":"Kini R. M. & Doley, R. Structure, function and evolution of three-finger toxins: Mini proteins with multiple targets. Toxicon 56, 855\u2013867 (2010).","journal-title":"Toxicon"},{"key":"BFsrep22385_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2004.02.007","volume":"425","author":"R Doley","year":"2004","unstructured":"Doley, R., King, G. F. & Mukherjee, A. K. Differential hydrolysis of erythrocyte and mitochondrial membrane phospholipids by two phospholipase A2 isozymes (NK-PLA2-I and NK-PLA2-II) from the venom of the Indian monocled cobra Naja Kaouthia. Arch. Biochem. Biophys. 425, 1\u201313 (2004).","journal-title":"Arch. Biochem. Biophys."},{"key":"BFsrep22385_CR18","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/157015906775203011","volume":"4","author":"T Yagami","year":"2006","unstructured":"Yagami, T. Cerebral arachidonate cascade in dementia: Alzheimer\u2019s disease and vascular dementia. Curr. Neuropharmacol. 4(1), 87\u2013100 (2006).","journal-title":"Curr. Neuropharmacol."},{"key":"BFsrep22385_CR19","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.3168","volume":"15","author":"RM Ransohoff","year":"2012","unstructured":"Ransohoff, R. M. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat. Neurosci. 15(8), 1074\u20131077 (2012).","journal-title":"Nat. Neurosci."},{"key":"BFsrep22385_CR20","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1172\/JCI58649","volume":"122","author":"A Nylander","year":"2012","unstructured":"Nylander, A. & Hafler, D. A. Multiple sclerosis. J. Clin. Invest. 122, 1180\u20131188 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFsrep22385_CR21","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1034\/j.1600-0404.2002.01238.x","volume":"106","author":"A Yegin","year":"2002","unstructured":"Yegin, A., Akbas, S. H., Ozben, T. & Korgun, D. K. Secretory phospholipase A2 and phospholipids in neural membranes in an experimental epilepsy model. Acta Neurol. Scand. 106(5), 258\u2013262 (2002).","journal-title":"Acta Neurol. Scand."},{"key":"BFsrep22385_CR22","doi-asserted-by":"crossref","unstructured":"Steinbach, J. H. & Stevens, C. F. Neuromuscular Transmisi\u00f3n. Frog Neurobiology A Handbook, (eds. Llinas, R. & Precht, W. ) Ch. 2, 33\u201377 (Springer, New York, 1976).","DOI":"10.1007\/978-3-642-66316-1_2"},{"key":"BFsrep22385_CR23","doi-asserted-by":"publisher","first-page":"96","DOI":"10.13181\/mji.v19i2.389","volume":"19","author":"EH Purwaningsih","year":"2010","unstructured":"Purwaningsih,E. H., Ibrahim, N. & Zain, H. The nerve protection and in vivo therapeutic effect of Acalypha indica extract in frogs, Med. J. Indones. 19(2), 96\u2013102 (2010).","journal-title":"Med. J. Indones."},{"key":"BFsrep22385_CR24","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.cub.2010.01.012","volume":"20","author":"JB Wallingford","year":"2010","unstructured":"Wallingford, J. B., Liu, K. J. & Zheng,Y. Xenopus, Curr. Biol. 20(6), 263\u2013264 (2010).","journal-title":"Curr. Biol."},{"key":"BFsrep22385_CR25","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.tig.2011.08.003","volume":"27","author":"RM Harland","year":"2011","unstructured":"Harland,R. M. & Grainer, R. M. Xenopus research:metamorphosis by genetics and genomics. Trends Genet. 27(12), 507\u2013515 (2011).","journal-title":"Trends Genet."},{"key":"BFsrep22385_CR26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.chaos.2005.09.077","volume":"31","author":"W Jiang","year":"2007","unstructured":"Jiang, W., Chen, L. & Yang, F. X. Analysis and control of the bifurcation of Hodgkin Huxley model. Chaos Soliton. Fract. 31, 247\u2013256 (2007).","journal-title":"Chaos Soliton. Fract."},{"key":"BFsrep22385_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1113\/jphysiol.1972.sp010036","volume":"227","author":"ZJ Koles","year":"1972","unstructured":"Koles, Z. J. & Rasminsky, M. A computer simulation of conduction in demyelinated nerve fibers J. Physiol. 227, 351\u2013364 (1972).","journal-title":"J. Physiol."},{"key":"BFsrep22385_CR28","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1109\/10.942593","volume":"48","author":"V Schnabel","year":"2001","unstructured":"Schnabel, V. & Johannes, J. S. Evaluation of the Cable Model for Electrical Stimulation of unmyelinated Nerve Fibers. IEEE Trans. Biomed. Eng. 48(9), 1027\u20131033 (2001).","journal-title":"IEEE Trans. Biomed. Eng."},{"key":"BFsrep22385_CR29","first-page":"101","volume":"1","author":"HK Das","year":"2013","unstructured":"Das, H. K. & Sahu, P. P. Effect of Demyelination on conduction velocity in demyelinating polyneuropathic patients. Int. J. Curr. Sci. Tech. 1(1), 101\u2013104 (2013).","journal-title":"Int. J. Curr. Sci. Tech."},{"key":"BFsrep22385_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.proeng.2013.09.099","volume":"64","author":"HK Das","year":"2013","unstructured":"Das, H. K. & Sahu, P. P. Coupled Nerve: A Technique to increase the Nerve Conduction Velocity in Demyelinating Polyneuropathic Patients. Proc. Eng. 64, 275\u2013282 (2013).","journal-title":"Proc. Eng."},{"key":"BFsrep22385_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/sj.bjp.0706868","volume":"149","author":"R Katsuki","year":"2006","unstructured":"Katsuki, R. et al. Tramadol, but not its major metabolite (mono-O-demethyl tramadol) depresses compound action potentials in frog sciatic nerves. Br. J. Pharmacol. 149, 319\u2013327 (2006).","journal-title":"Br. J. Pharmacol."},{"key":"BFsrep22385_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jprot.2015.02.012","volume":"120","author":"KY Tan","year":"2015","unstructured":"Tan, K. Y., Tan, C. H., Fung, S. Y. & Tan, N. H. Venomics, lethality and neutralization of Naja kaouthia (monocled cobra) venoms from three different geographical regions of Southeast Asia. J Proteomics 120, 105\u2013125 (2015).","journal-title":"J Proteomics"},{"key":"BFsrep22385_CR33","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1073\/pnas.88.6.2437","volume":"88","author":"JR De Weille","year":"1991","unstructured":"De Weille, J. R., Schweitz, H., Maes, P., Tartar, A. & Lazdunski, M. Calciseptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel. Proc. Natl. Acad. Sci. 88, 2437\u201340 (1991).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"BFsrep22385_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/(SICI)1097-0282(200007)54:1<44::AID-BIP50>3.0.CO;2-Z","volume":"54","author":"E Katoh","year":"2000","unstructured":"Katoh, E. et al. Structural basis for the biological activity of dendrotoxin-I, a potent potassium channel blocker. Biopolymers 54, 44\u201357 (2000).","journal-title":"Biopolymers"},{"key":"BFsrep22385_CR35","doi-asserted-by":"publisher","first-page":"5692","DOI":"10.1021\/bi00072a026","volume":"32","author":"LA Smith","year":"1993","unstructured":"Smith, L. A., Lafaye, P. J., LaPenotiere, H. F., Spain, T. & Dolly, J. O. Cloning and functional expression of dendrotoxin K from black mamba, a K+ channel blocker. Biochem. 32, 5692\u20135697 (1993).","journal-title":"Biochem."},{"key":"BFsrep22385_CR36","first-page":"287","volume":"21","author":"O Yasuda","year":"1994","unstructured":"Yasuda, O. et al. FS2. a mamba venom toxin, is a specific blocker of the L-type calcium channels. Artery 21, 287\u2013302 (1994).","journal-title":"Artery"},{"key":"BFsrep22385_CR37","doi-asserted-by":"crossref","unstructured":"Das, D., Sharma, M., Das, H. K., Sahu, P. P. & Doley, R. Purification and Characterization of Nk-3FTx, A Three Finger Toxin (3FTx) from the venom of North East Indian Monocled Cobra. J. Biochem. Mol. Toxicol., doi: 10.1002\/jbt.21734 (2015).","DOI":"10.1002\/jbt.21734"},{"key":"BFsrep22385_CR38","first-page":"31","volume":"4","author":"D Das","year":"2013","unstructured":"Das, D., Urs, N., Hiremath, V., Vishwanath, B. S. & Doley, R. Biochemical and biological characterization of Naja kaouthia venom from North-East India and its neutralization by polyvalent antivenom. J. Venom Res. 4, 31\u201338 (2013).","journal-title":"J. Venom Res."},{"key":"BFsrep22385_CR39","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry, O. H., Rosebrough, N. J., Farr, A. L. & Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265\u2013275 (1951).","journal-title":"J. Biol. Chem."},{"key":"BFsrep22385_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0041-0101(02)00213-1","volume":"41","author":"R Doley","year":"2003","unstructured":"Doley, R. & Mukherjee, A. K. Purification and characterization of an anticoagulant phospholipase A2 from Indian monocled cobra (Naja kaouthia) venom. Toxicon 41, 81\u201391(2003).","journal-title":"Toxicon"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep22385","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep22385.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T13:44:10Z","timestamp":1672839850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep22385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,2]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,4,20]]}},"alternative-id":["BFsrep22385"],"URL":"https:\/\/doi.org\/10.1038\/srep22385","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,2]]},"assertion":[{"value":"24 September 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22385"}}